H. Res. 456 (119th)Bill Overview

Expressing support for the designation of the month of May 2025 as "Progressive Supranuclear Palsy Awareness Month".

Simple ResolutionHealth|Health
Cosponsors
Support
Lean Democratic
Introduced
May 29, 2025
Discussions
Bill Text
Current stageCommittee

Referred to the House Committee on Energy and Commerce.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Simple ResolutionWhat this resolution actually does

This resolution expresses the House of Representatives' support for designating May 2025 as Progressive Supranuclear Palsy Awareness Month. It is a non-binding statement by one chamber and does not create law or require the President's approval. The text encourages awareness, research, support services, and better care for people affected by the disease. It also recognizes and commends researchers, caregivers, organizations, and families working on PSP.

This House resolution expresses support for designating May 2025 as "Progressive Supranuclear Palsy Awareness Month." It describes PSP’s symptoms, prevalence estimates, lack of disease-modifying treatments, and the need for research, support services, and education.

The resolution affirms support for awareness goals, research toward treatments and a cure, and commends researchers, volunteers, families, and organizations.

It is a non‑binding, symbolic statement and does not authorize funding or regulatory changes.

Passage2/100

As a House simple resolution it does not become law; adoption by the House is likely but statutory enactment requires additional, unlikely steps.

CredibilityAligned

Relative to its intended legislative type, this bill is a straightforward commemorative House resolution that clearly defines the health condition it highlights and appropriately limits itself to expressing support for an awareness month and related goals.

Contention10/100

All support awareness; liberals push for funding, conservatives stress no new spending

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Likely helpedFederal agencies

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Potential benefitRaises public and clinical awareness of PSP, potentially improving recognition and referrals.
  • Potential benefitSignals Congressional recognition that may encourage researchers and funders to prioritize PSP studies.
  • Potential benefitMay increase fundraising and philanthropic donations for PSP organizations and research efforts.
Likely burdened
  • Federal agenciesCreates no new federal funding, legal authority, or entitlement for PSP research or care.
  • Potential burdenIs symbolic only and may create public expectations without delivering concrete services or support.
  • Potential burdenUses Congressional time for a nonbinding resolution that critics may view as low legislative priority.
03 · Why people split

Why the argument around this bill splits.

All support awareness; liberals push for funding, conservatives stress no new spending
Progressive95%

Likely welcomes the designation as an important step to spotlight a neglected neurodegenerative disease and to support patients, caregivers, and research.

Would view the resolution positively but note it’s symbolic without explicit funding or policy actions.

Leans supportive
Centrist85%

Views the resolution as a low‑cost, bipartisan acknowledgement that can help patients and researchers.

Sees it as sensible but incomplete without specific implementation or funding mechanisms.

Leans supportive
Conservative80%

Likely accepts the resolution as harmless recognition of a disease and supportive of families and researchers, while emphasizing limited federal action.

Prefers private-sector and state-led solutions over new federal spending.

Leans supportive
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood2/100

As a House simple resolution it does not become law; adoption by the House is likely but statutory enactment requires additional, unlikely steps.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • Whether the House will schedule the resolution for floor consideration
  • Existence or prospect of a companion Senate resolution
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

All support awareness; liberals push for funding, conservatives stress no new spending

As a House simple resolution it does not become law; adoption by the House is likely but statutory enactment requires additional, unlikely…

Unlocked analysis

Relative to its intended legislative type, this bill is a straightforward commemorative House resolution that clearly defines the health condition it highlights and appropriately limits itself to expressing support for…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis